Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives
Sign Up to like & getrecommendations! Published in 2021 at "Neurotherapeutics"
DOI: 10.1007/s13311-021-01008-7
Abstract: Coronavirus SARS-CoV2 has emerged as one of the greatest infectious disease health challenges in a century. Patients with multiple sclerosis (MS) have a particular vulnerability to infections through their use of immunosuppressive disease-modifying therapies (DMTs).… read more here.
Keywords: sclerosis; potential risks; risks benefits; benefits multiple ... See more keywords